🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Lexeo Therapeutics, Inc.

LXEO Healthcare
$4.2 +$0.02 (0.48%)
Market Cap: $344.58 M
Gurus Holding
3
Popularity Rank
#3196
% of Shares Held
0.76%
Net Activity (Q2 2026)
-$8.33 M

Guru Ownership Trend

Guru Analysis for Lexeo Therapeutics, Inc. (LXEO)

Lexeo Therapeutics, Inc. (LXEO), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.61 M.

Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $8.33 M net outflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who opened a new position. Conversely, Cliff Asness reduced exposure by 24.4%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$1.7 M
Total Buy Value
New Buys 2
Additions 0
-$10.03 M
Total Sell Value
Reductions 1
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
2
Net Buyers
2

FAQs for Lexeo Therapeutics, Inc. (LXEO)

Major holders include Cliff Asness ($1.19 M), Renaissance Technologies (RenTech) ($1.17 M), Ken Fisher ($532,168). According to the latest reported data, 3 tracked investment managers collectively hold approximately 621,348 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $8.33 M, with 2 managers increasing positions and 2 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited LXEO. The total reported sell value was $10.03 M.

Yes, 2 managers opened new positions in LXEO, and 0 increased their existing holdings. The total reported buy value was $1.7 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Reduce -24.4% 256,661 $1.19 M Q2 2026
0.00% New Buy 250,365 $1.17 M Q2 2026
0.00% New Buy 114,322 $532,168 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form